Late CD8+ T Cell-Dependent Xenoantibody Production in Innate Tolerant Nude Rats After Hamster Islet Grafting But Not After Hamster Heart Grafting

Transplantation

Volumn 85, Issue 10, 2008, Pages 1489-1495

  Devos, Timothy ^a   Shengqiao, Li ^a   Gysemans, Conny ^a   Yan, Yehong ^a   Van Damme, Boudewijn ^a   Nelson Holte, Molly ^a   Billiau, An D ^a   Waer, Mark ^a,b   Mathieu, Chantal ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Campus Gasthuisberg ^*  (Belgium)

Author keywords

B cell tolerance; Cellular and vascular xenografts; Tolerizing regimen; Xenoantibody

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEFLUNOMIDE; MONOCLONAL ANTIBODY OX 38; UNCLASSIFIED DRUG; HETEROPHILE ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOPATHOLOGY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE DEPLETION; NATURAL KILLER CELL; NONHUMAN; NUDE RAT; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RAT; SYRIAN HAMSTER; XENOGRAFT; ANIMAL; ANTIBODY SPECIFICITY; GRAFT SURVIVAL; HAMSTER; IMMUNOLOGY; T LYMPHOCYTE; TIME;

ANIMALS; ANTIBODIES, HETEROPHILE; CD8-POSITIVE T-LYMPHOCYTES; CRICETINAE; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE TOLERANCE; ISLETS OF LANGERHANS TRANSPLANTATION; ORGAN SPECIFICITY; RATS; RATS, NUDE; T-LYMPHOCYTES; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 48649105805     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31816f24af     Document Type: Article

References (17)

1. Cascalho M, Platt JL. The immunological barrier to xenotransplantation. Immunity 2001; 14: 437.
2. Fox A, Mountford J, Braakhuis A, et al. Innate and adaptive immune responses to nonvascular xenografts: Evidence that macrophages are direct effectors of xenograft rejection. J Immunol 2001; 166: 2133.
3. Fox A, Harrison LC. Innate immunity and graft rejection. Immunol Rev 2000; 173: 141.
4. Lin Y, Goebels J, Xia G, et al. Induction of specific transplantation tolerance across xenogeneic barriers in the T-independent immune compartment. Nature Med 1998; 4: 173.
5. Yan Y, Verbeken E, Yu L, et al. Effects of a short course of leflunomide on T-independent B lymphocyte xenoreactivity and on susceptibility of xenografts to acute or chronic rejection. Transplantation 2005; 79: 135.
6. Xia G, Ji P, Rutgeerts O, et al. Maintenance and reversibility of natural killer cell- and T cell-independent B lymphocyte xenotolerance in athymic nude rats. Transplantation 1999; 68: 1181.
7. Rood PPM, Cooper DKC. Islet xenotransplantation: Are we really ready for clinical trials? Am J Transplant 2006; 6: 1269.
8. Gysemans CA, Waer M, Valckx D, et al. Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-beta mRNA in the grafts. Diabetes 2000; 49: 1992.
9. Lin Y, Soares MP, Sato K, et al. Rejection of cardiac xenografts by CD4- and CD8- T cells. J Immunol 1999; 162: 1206.
10. Lake SP, Chamberlain J, Husken P, et al. In vivo assessment of isolated pancreatic islet viability using the streptozotocin-induced diabetic nude rat. Diabetologia 1988; 31: 390.
11. Miyatake T, Sato K, Takigami K, et al. Complement-fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection. J Immunol 1998; 160: 4114.
12. Bach F, Ferran C, Hechenleitner P, et al. Accomodation of vascularized xenografts: Expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med 1997; 3: 196.
13. Simeonovic CJ, McKenzie KU, Wilson JD, et al. Role of anti-donor antibody in the rejection of pig proislet xenografts in mice. Xenotransplantation 1998; 5: 18.
14. Bruggemann M, Teale C, Clark M, et al. A matched set of rat/mouse chimeric antibodies. Identification and biological properties of rat H chain constant regions mu, gamma 1, gamma 2a, gamma 2b, gamma 2c, epsilon and alpha. J Immunol 1989; 142: 3145.
15. Yi S, Hawthorne WJ, Lehnert AM, et al. T cell-activated macrophages are capable of both recognition and rejection of pancreatic islet xenografts. J Immunol 2003; 170: 2750.
16. Wang B, Norbury CC, Greenwood R, et al. Multiple paths for activation of naÏve CD8- T cells: CD4-independent help. J Immunol 2001; 167: 1283.
17. Valujskikh A, Lantz O, Celli S, et al. Cross-primed CD8- T cells mediate graft rejection via a distinct effector pathway. Nat Immunol 2002; 3: 844.